- Fiasp® formulation and onset
- Dosing schedule and dose timing options
- Clinical study results
Novo Nordisk Medical Director Dr Karen Salvesen-Sykes quickly explains what makes Fiasp® different from other mealtime insulins.
Fiasp® (insulin aspart injection) 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adults with diabetes mellitus.
Please click here for Prescribing Information.